Non-target mRNAs with partial seed complementarity

Non-target mRNAs with partial seed complementarity refer to a broad class of transcripts that are unintentionally regulated by RNA-based therapeutics, such as small interfering RNAs (siRNAs) or microRNAs (miRNAs) (Jackson et al., 2003, Nature Biotechnology). This phenomenon occurs when the 'seed region' of the therapeutic RNA—specifically nucleotides 2 through 8 of the guide strand—exhibits complementarity to sequences within the 3' untranslated region (UTR) of unintended mRNAs (Birmingham et al., 2006, Nature Methods). This interaction mimics the natural regulatory mechanism of endogenous microRNAs, leading to unintended gene silencing through mRNA degradation or translational repression (Fedorov et al., 2006, RNA). Because these off-target effects can result in cellular toxicity and adverse clinical outcomes, they represent a major safety concern in the development of oligonucleotide drugs (Burchard et al., 2009, Nature Biotechnology). Strategies to mitigate these risks include the use of chemical modifications, such as 2'-O-methyl substitutions, and advanced computational algorithms to select sequences with minimal transcriptome-wide seed matches (Vaish et al., 2011, Nucleic Acids Research).

Other names

Off-target mRNAsSeed-mediated off-targetsmiRNA-like off-target effectssiRNA off-targets

Unintended sequence-specific binding of therapeutic oligonucleotides to non-target mRNA transcripts via seed-region complementarity (nucleotides 2-8), leading to RISC-mediated mRNA degradation or translational repression (Jackson et al., 2003, Nature Biotechnology).